Prebiotic xylooligosaccharides ameliorate metabolic dysfunction-associated steatotic liver disease via modulating gut microbiota and metabolites
Crossref DOI link: https://doi.org/10.1038/s41598-026-48643-8
Published Online: 2026-04-12
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Chen, Li
Shan, Ti-Dong
Text and Data Mining valid from 2026-04-12
Accepted Manuscript valid from 2026-04-12
Article History
Received: 17 September 2025
Accepted: 9 April 2026
First Online: 12 April 2026
Declarations
:
: The authors declare no competing interests.